Navana Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	163.42	184.53	267.77	440.93	66.43	25.78
Cash & Short-Term Investments	163.42	184.53	267.77	440.93	66.43	25.78
Cash Growth	-39.66%	-31.09%	-39.27%	563.78%	157.71%	-52.89%
Accounts Receivable	1,389	1,360	996.56	788.15	519.97	434.81
Other Receivables	32.18	16.12	23.57	13.09	27.85	28.08
Receivables	1,421	1,376	1,020	801.24	547.82	462.89
Inventory	2,128	2,086	2,303	1,554	1,170	931.44
Prepaid Expenses	-	-	-	0.95	2.59	1.98
Other Current Assets	1,530	1,536	1,890	1,993	1,109	387.04
Total Current Assets	5,242	5,182	5,480	4,789	2,895	1,809
Property, Plant & Equipment	6,170	6,256	5,746	4,632	4,029	3,389
Long-Term Investments	55.39	34.46	76.92	167.62	159.03	-
Other Intangible Assets	0.06	0.11	0.33	0.55	0.77	0.99
Other Long-Term Assets	-0	-	-	-	-	0
Total Assets	11,468	11,472	11,304	9,590	7,084	5,199
Accounts Payable	74.29	83.92	23.79	44.46	42.65	20.43
Accrued Expenses	769.87	639.15	444.32	298.32	245.36	185.09
Short-Term Debt	3,905	4,283	5,008	4,066	2,682	1,143
Current Portion of Long-Term Debt	47.06	85.76	35.37	18.09	28.13	18.8
Current Portion of Leases	40.86	45.85	43.55	34.72	29.25	34.62
Current Income Taxes Payable	688.87	616.02	451.2	345.48	245.11	141.44
Other Current Liabilities	298.7	292.67	288.36	47.84	14.02	28.31
Total Current Liabilities	5,825	6,047	6,295	4,855	3,287	1,572
Long-Term Debt	140.79	118.66	225.32	120.63	171.39	162.98
Long-Term Leases	101.67	115.35	64.5	89.6	100.72	131.53
Long-Term Deferred Tax Liabilities	349.14	326.71	158.01	152.11	42.36	28.25
Other Long-Term Liabilities	-0	-	-	0	-	-0
Total Liabilities	6,416	6,607	6,743	5,217	3,601	1,895
Common Stock	1,074	1,074	1,074	1,074	802.3	802.3
Additional Paid-In Capital	448.17	448.17	448.17	448.17	-	-
Retained Earnings	1,332	1,148	708.02	443.03	204.24	535.83
Comprehensive Income & Other	2,198	2,194	2,331	2,407	2,477	1,966
Shareholders' Equity	5,052	4,865	4,561	4,372	3,483	3,304
Total Liabilities & Equity	11,468	11,472	11,304	9,590	7,084	5,199
Total Debt	4,235	4,649	5,377	4,329	3,012	1,491
Net Cash (Debt)	-4,017	-4,430	-5,032	-3,721	-2,786	-1,466
Net Cash Per Share	-37.27	-41.24	-46.85	-37.42	-34.73	-18.27
Filing Date Shares Outstanding	107.42	107.42	107.42	107.42	80.23	80.23
Total Common Shares Outstanding	107.42	107.42	107.42	107.42	80.23	80.23
Working Capital	-582.29	-864.47	-814.39	-65.55	-391.14	237.08
Book Value Per Share	47.03	45.29	42.46	40.71	43.41	41.19
Tangible Book Value	5,052	4,865	4,561	4,372	3,482	3,303
Tangible Book Value Per Share	47.03	45.29	42.46	40.70	43.40	41.17
Land	2,483	2,483	2,483	2,483	2,483	2,483
Buildings	1,831	1,700	1,415	1,142	745.82	231.9
Machinery	2,358	2,330	1,708	985.02	831.81	789.03
Construction In Progress	666.17	821.13	931.72	614.67	403.01	159.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.